Keyphrases
Platelets
84%
Platelet Transfusion
35%
Thrombocytopenia
30%
HIV Infection
28%
African American
28%
Thromboxane
26%
Cocaine Use
24%
Alloimmunised
24%
Red Cells
23%
Immune Thrombocytopenia
23%
Aspirin
22%
COVID-19
22%
Transfusion
20%
HIV Patients
19%
Thromboxane B2 (TXB2)
19%
Neonatal Alloimmune Thrombocytopenia
17%
Enzyme-linked Immunosorbent Assay (ELISA)
17%
Heparin-induced Thrombocytopenia
16%
Coronary Artery Bypass Graft Surgery
16%
Human Platelet Antigens
15%
Platelet Activation
14%
11-dehydrothromboxane B2
13%
Platelet Glycoproteins
13%
Alloantigen
12%
Confidence Interval
12%
Systemic Lupus Erythematosus
12%
Emergency Department
12%
Alloantibody
11%
Heparin
11%
Specific Antigen
10%
Thromboxane A2 (TXA2)
10%
Clinical Correlation
10%
Myocardial Infarction
10%
Platelet Aggregation
10%
Baltimore
10%
Antiretroviral Therapy
10%
Saphenous Vein Graft
10%
Endothelial Dysfunction
10%
Heparin Antibodies
10%
Platelet Reactivity
10%
Cross-matching
10%
Survivors
10%
Red Cell Survival
10%
Cocaine Users
10%
Alloimmunization
9%
Vein Graft Occlusion
9%
Unfractionated Heparin
9%
Posttransfusion Purpura
9%
Hospitalized Patients
8%
Platelet Count
8%
Medicine and Dentistry
Platelet
100%
Thrombocyte Transfusion
35%
Thrombocytopenia
34%
Human Immunodeficiency Virus
29%
Disease
20%
Acetylsalicylic Acid
20%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Emergency Department
20%
Hemostat
19%
Human Immunodeficiency Virus Infection
19%
Infection
18%
Thrombosis
17%
Thromboxane
16%
Neonatal Alloimmune Thrombocytopenia
16%
Clinical Trial
16%
Venous Thromboembolism
15%
Evans Syndrome
15%
Coronary Artery Disease
15%
Heparin
13%
Systemic Lupus Erythematosus
13%
COVID-19
13%
Odds Ratio
13%
Immunoglobulin
12%
Immunoglobulin M
12%
Bone Marrow Transplantation
12%
Thrombocyte Concentrate
12%
PADGEM Protein
12%
Erythrocyte
11%
Prevalence
11%
Thrombocyte Activation
11%
Coronary Artery Bypass Graft Surgery
11%
Heparin-Induced Thrombocytopenia
11%
In Vitro
10%
Thrombin
10%
Blood Transfusion Reaction
10%
Extracorporeal Membrane Oxygenation
10%
Sepsis
10%
Cardiac Graft Rejection
10%
Heart Surgery
10%
Plasmapheresis
10%
Troponin T
10%
Cardiac Troponin
10%
Platelet Reactivity
10%
Epileptic Absence
9%
Thromboxane B2
9%
Neonatal Thrombocytopenia
9%
Cardiovascular Risk
9%
Myocardial Infarction
9%
D-Dimer
9%
C Reactive Protein
8%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
36%
HIV
32%
Human Immunodeficiency Virus Infection
30%
Thromboplastin
30%
Thromboxane
26%
Venous Thromboembolism
21%
Heparin Induced Thrombocytopenia
21%
Enzyme-Linked Immunosorbent Assay
21%
Acetylsalicylic Acid
20%
SARS Coronavirus
20%
Disease
19%
Thromboxane B2
18%
Thrombocytopenia
16%
Immunoglobulin Antibody
16%
Infection
15%
Hemostatic Agent
15%
Purpura
15%
Prevalence
14%
Thrombosis
14%
Thrombin
13%
Coronary Artery Disease
13%
Cardiovascular Risk
13%
Epileptic Absence
12%
Bleeding
12%
Coronary Artery Atherosclerosis
12%
Prothrombin
11%
Endothelin 1
11%
Creatinine
11%
Blood Transfusion Reaction
10%
Antiplatelet
10%
Duragesic
10%
Endothelial Dysfunction
10%
Randomized Clinical Trial
10%
Thrombotic Thrombocytopenic Purpura
10%
Ticagrelor
10%
Coronary Artery Obstruction
9%
D Dimer
9%
Glycoprotein
9%
Monoclonal Antibody
9%
Heart Infarction
8%
P-Selectin
8%
Neonatal Alloimmune Thrombocytopenia
8%
Alloantibody
7%
Atherosclerosis
7%
Von Willebrand Factor
7%
Adenosine Diphosphate
7%
Thrombocyte Concentrate
7%
Remission
7%
Blood Clotting Factor
7%
Cardiovascular Disease
6%